Rule 15c2-11 Information

1. The exact name of the issuer and its predecessor (if any):  Bexil Corporation

2. The address of its principal executive offices:  
        11 Hanover Square
        New York, NY 10005

3. The state of incorporation, if it is a corporation:  Maryland

4. The exact title and class of the security:  
        Common Stock, $.01 par value
        Rights to Purchase Series A Participating Preferred Stock, $.01 par value

5. The number of shares or total amount of the securities outstanding as of the end of the issuer's most recent fiscal year:

        Common Stock, 9,900,000 shares authorized, 883,592 issued and outstanding as of December 31, 2008.
        Rights to Purchase Series A Participating Preferred Stock, 100,000 shares authorized, 0 shares issued and outstanding as of December 31, 2008.

6. The name and address of the transfer agent:  
        Illinois Stock Transfer Company
        209 West Jackson Boulevard, Suite 903
        Chicago, IL 60606

7. The nature of the issuer's business:  Holding company.

8. The nature of products or services offered:  Operating businesses directly or through companies in which it has a majority or other substantial interest.

9. The nature and extent of the issuer's facilities:  leased office space at 11 Hanover Square, New York, NY 10005   

10. The name of the chief executive officer and members of the board of directors:
        CEO – Thomas B. Winmill.
        Members of the Board of Directors – Charles A. Carroll, Edward G. Webb, Jr., Douglas Wu, Bassett S. Winmill, Thomas B. Winmill

11. The issuer's most recent balance sheet and profit and loss and retained earnings statements:  See the Company's most recent annual report.

12. Similar financial information for such part of the 2 preceding fiscal years as the issuer or its predecessor has been in existence: See the Company's most recent annual report.